Latest News

AI Eye Podcast 730: Stocks discussed: (NasdaqGS: $AMZN) (NYSE: $ORCL) (NasdaqGS: $NVDA)

Vancouver, Kelowna, Delta, BC – October 18, 2022 ( Newswire), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:

AI Eye Podcast 730: Stocks discussed: (NasdaqGS: AMZN) (NYSE: ORCL) (NasdaqGS: NVDA)


Hear the AI Eye on Spotify

Today’s Column – The AI Eye – Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:AMZN) (NYSE:ORCL) (NasdaqGS:NVDA)

Amazon Web Services (AWS), a subsidiary of Amazon (NasdaqGS:AMZN), has announced plans to launch an infrastructure Region in Thailand. This AWS Asia Pacific (Bangkok) Region will “enable developers, startups, and enterprises, as well as government, education, and nonprofit organizations, to run their applications and serve end users from AWS data centers located in Thailand.” Prasad Kalyanaraman, vice president of Infrastructure Services at AWS, said:

“The AWS Asia Pacific (Bangkok) Region will enable organizations to build with AWS technologies like artificial intelligence and machine learning, data analytics, and Internet of Things. With these new tools, AWS is empowering governments to better engage with citizens, enterprises to innovate for their next phase of growth, and entrepreneurs to build businesses and compete on a global scale.”

Oracle Corporation (NYSE:ORCL) and NVIDIA Corporation (NasdaqGS:NVDA) have announced a multi-year partnership aimed at helping customers solve business challenges with accelerated computing and AI, by bringing the full NVIDIA accelerated computing stack to the Oracle Cloud Infrastructure (OCI). Jensen Huang, CEO and founder, NVIDIA, said:

“Accelerated computing and AI are key to tackling rising costs in every aspect of operating businesses. Enterprises are increasingly turning to cloud-first AI strategies that enable fast development and scalable deployment. Our partnership with Oracle will put NVIDIA AI within easy reach for thousands of companies.”

Global AI in Clinical Trials Market to reach $4.8B by 2027

A report published by Markets and Markets finds that the global AI in Clinical Trials market is projected to grow from $1.5 billion USD in 2022 to $4.8 billion by 2027, registering a compound annual growth rate (CAGR) of 25.6 percent in the forecast period. The following excerpt from the report’s description outlines some factors influencing the market’s growth:

The growing need to curb clinical trials costs and reduce time involved in the drug development process, the rising adoption of cloud-based applications and services, and the impending patent expiry of blockbuster drugs are some of the key factors driving the growth of artificial intelligence in clinical trials market.

However, a shortage of AI workforce and ambiguous regulatory guidelines for medical software and lack of data sets in this field are some of the factors expected to restrain the growth of the AI in clinical trials market in the coming years.

Sam Mowers,

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on visit here

About – Big Investing Ideas

We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast, Play by Play Sports Podcast, Cannabis News and Stocks on the Move Podcast, Cleantech and Climate Change Podcast, Exploring Mining Podcast, Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.

The podcasts are also available on Apple Podcasts, Audible, Spotify, Tunein, Stitcher,, iHeartRadio, Google Podcasts and most audio platforms available.

Visit the Podcast page at

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: Learn more about publishing your news release and our other news services on the newswire Global investors must adhere to regulations of each country. Please read privacy policy:

The AI Eye – Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of

The AI Eye – Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of

Follow us on Twitter

Follow us on Facebook

Follow us on YouTube


800 665 0411

Buy a technology guest post on

What's your reaction?

In Love
Not Sure

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News